Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - venlafaxina - cápsula de libertação prolongada - 37.5 mg - venlafaxina, cloridrato 42.429 mg - venlafaxine - genérico - duração do tratamento: longa duração

Европска Унија - Португалски - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - rejeição de enxerto - imunossupressores - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Европска Унија - Португалски - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidina - leucemia, mieloide, aguda - agentes antineoplásicos - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

kalceks, as - fentanilo - solução injetável - 0.05 mg/ml - fentanilo, citrato 0.0785 mg/ml - fentanyl - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

kalceks, as - fentanilo - solução injetável - 0.05 mg/ml - fentanilo, citrato 0.0785 mg/ml - fentanyl - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

kalceks, as - fentanilo - solução injetável - 0.05 mg/ml - fentanilo, citrato 0.0785 mg/ml - fentanyl - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - cinacalcet - comprimido revestido por película - 60 mg - cinacalcet, cloridrato 66.13 mg - cinacalcet - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - cinacalcet - comprimido revestido por película - 90 mg - cinacalcet, cloridrato 99.19 mg - cinacalcet - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

boiron, s.a. - n/a - pomada - associação - achillea millefolium, planta fresca achillea millefolium, planta fresca ; pulsatilla (ff) 1.5 g ; calendula officinalis, planta fresca calendula officinalis, planta fresca ; hypericum perforatum, planta fresca hypericum perforatum, planta fresca ; ledum palustre 1.5 g - preparations for treatment of wounds and ulcers - homeopático - duração do tratamento: curta ou média duração

Европска Унија - Португалски - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidone - esquizofrenia - psicolepticos - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.